Concurrent acute infections like group A streptococcus and Epstein-Barr virus do not rule out Kawasaki syndrome, and immunoglobulin therapy should still be considered in highly suggestive cases.
No takes yet. Share an insight, caveat, or question.
Supports Kawasaki evaluation despite concurrent infections in suggestive cases; hypothesis-generating and should not yet change practice.
Barton et al. (2002) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: